You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Genome Biology this week: DNA methylation features found among neurodegenerative disorders, analysis of somatic variants in the brain, and more.
According to the New York Times, the Biden Administration is establishing a task force to review government interference in science.
Vice's Motherboard reports that Stanford University researchers sequenced the RNA used in two SAR-CoV-2 vaccines.
The Financial Times writes that budget cuts in the UK could affect its scientific reputation.
In PNAS this week: Australasian-related ancestry among South Americans, gene expression in venom production, and more.
A bill seeks to increase the National Science Foundation budget and establish a new directorate there, according to Science.
The World Health Organization is to release a report saying bats are the most likely source of SARS-CoV-2, the Associated Press reports.
Amazon receives authorization for a COVID-19 test it plans to use in an employee-screening program, the Verge reports.
In PLOS this week: analysis of differentiating neurons, genome-wide association study of fish oil supplement response, and more.
The editor-in-chief of the Journal of the American Medical Association has been placed on leave following a controversial podcast on structural racism, the New York Times reports.
Nature News reports the University of Liverpool is under criticism for using research metrics to identify researchers whose positions may be at risk.
Researchers have uncovered a gene alteration tied to why sauteur d'Alfort rabbits walk on their front legs, New Scientist reports.
In Science this week: a review of how the gut microbiome influences cancer risk, and more.
The Wall Street Journal reports Moncef Slaoui has been fired from a biotech startup following allegations of sexual harassment.
In a new analysis, AstraZeneca says its SARS-CoV-2 vaccine is 76 percent effective in preventing symptomatic COVID-19, the Associated Press reports.
The UK is launching a new health agency to prevent and response to future pandemics, according to the Guardian.
In Nature this week: framework for balancing population genomics research and privacy, single-cell transcriptomic analysis of neuroblastomas, and more.
According to Science, Roche is ending its late-stage clinical trial of an antisense therapy for Huntington's disease.
Thermo Fisher Scientific has developed a device to detect SARS-CoV-2 from the air, the New York Times reports.
Researchers are developing a saliva-based test to diagnose concussions, according to the Washington Post.
In Cell this week: genomic analysis of population history in Central America, analysis of immune responses following vaccination to SARS-CoV-2 viral variants, and more.
US officials have raised concerns that the data AstraZeneca released from its SARS-CoV-2 vaccine trial was outdated, the New York Times reports.
NPR reports that efforts to vaccinate great apes and other animals against SARS-CoV-2 aim to prevent spread between humans and them and vice versa.
Florida Politics reports that a bill is making its way through the Florida Senate that would make unauthorized DNA analysis a felony.
In PNAS this week: sequencing analysis of historical migrations to the Philippines, adaptations among snowfinches, and more.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.